Venture Life Repurchases 73,427 Shares Under Ongoing Buyback Programme

The latest announcement is out from Venture Life ( (GB:VLG) ).

Venture Life Group has continued its previously announced share buyback programme with the repurchase of 73,427 ordinary shares at a volume-weighted average price of 65.08 pence per share, with the shares to be held in treasury. Following this transaction, the company now has 128,812,145 ordinary shares in issue, of which 3,457,368 are held in treasury, leaving 125,354,777 voting rights outstanding, a change that may affect shareholder disclosure thresholds under UK transparency rules.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £65.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group is a UK-headquartered international consumer self-care company focused on the global self-care market. Its portfolio includes products such as Balance Activ for women’s intimate health, Earol for ENT care, Lift and Glucogel for energy and glucose management and hypoglycaemia, and the Health & Her range supporting the hormonal lifecycle, sold through pharmacies, health and beauty retailers, grocery multiples and e-commerce channels worldwide, either directly or via distribution partners.

Average Trading Volume: 218,601

Technical Sentiment Signal: Buy

Current Market Cap: £81.34M

See more data about VLG stock on TipRanks’ Stock Analysis page.